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Abstract 
Background: To evaluate the use of 
electrocardiography (ECG) in thalassemia major 
patients, for the early detection of iron overload 
induced cardiac complications. 
Methods: Serum ferritin analysis and a standard 12 
lead ECG was performed on 135   thalassemia major 
patients. SPSS Version 20 was used for data analysis. 
For categorical variables, frequencies and 
percentages were calculated. For quantitative 
variables, mean with standard deviation was 
calculated. Chi Square test was used for finding 
association between different ECG changes and 
serum ferritin levels.  A p value of <0.05 was 
considered to be statistically significant. 
Results: Patients ranged in age from 7-30 years. 
Males constituted 51 %. The mean serum ferritin 
level was 6062.61 + 3641.796 ng/ml.  There was no 
significant difference between the mean ferritin 
levels in males and females (p =0.366) One or more 
abnormal electrocardiographic findings were 
observed in 88.1% of patients. The most commonly 
observed findings were flattening of the T wave, 
followed by arrthymias, tachycardia, pathological T 
wave inversions, long QT interval, left ventricular 
hypertrophy (LVH) and right ventricular 
hypertrophy (RVH). Long QT interval was the only 
abnormality found to be significantly associated 
with high ferritin levels. (p =0.001).  
Conclusion: ECG can be used for monitoring 
thalassaemia major patients for the development of 
cardiac complications, especially where magnetic 
resonance imaging (MRI) is not available   
Key Words : Thalassemia Major, Iron overload, 
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Introduction 
Thalassemia is a monogenic disorder characterised by 
decreased synthesis of the globin chain; a component 
of  hemoglobin .The most severely affected are the 
thalassaemia major (TM) patients, who despite regular  
blood transfusions  still have poor prospects for 
survival.1  According to the Thalassemia International 
Federation, the best way to transfuse these patients is 
by giving them group and type specific packed red 
cells. As a consequence of repeated blood transfusions, 
and excessive  iron absorption from the gut, iron 
overload takes place. 2 Cardiac complications 
attributable to iron deposition in the heart are the 
foremost cause of death in these patients. 3 Thus, the 
purpose of iron chelation therapy is the prevention of 
cardiac iron deposition. Keeping serum ferritin and 
liver iron concentration at a low level are essential 
therapeutic goals, however, even so complete cardiac 
protection cannot be guaranteed.This study was 
performed with the aim of considering the use of ECG, 
in the early detection of cardiac involvement in 
thalassemia major patients, in countries with economic 
barriers to provision of affordable MRI facilities. 4,5 
 
Patients and  Methods 
A cross-sectional study was conducted at Ziauddin 
University after approval by the Ethics Review 
Committee of the University. A random selection of a 
hundred and thirty five TM  patients coming for 
routine blood transfusion at the Fatimid Foundation, 
Karachi was carried out. Patients included in the study 
were 7 years of age and above, and receiving chronic 
transfusion therapy, which is defined as at least 8 
transfusions per year.4 All patients were on variable 
levels of chelation therapy. A patient was excluded 
from the study if he/she was found to have any acute 
illness, known congenital or acquired cardiac 
problems, severe liver, kidney or thyroid disease, 
diabetes mellitus, any other hemoglobinopathy, had 
undergone bone marrow transplantation or was 
receiving  medication known to affect the length of the 
QT interval . Written, informed consent was taken 
from adult patients and in case of children, from their 
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guardians.History of each patient was taken, height 
and weight was recorded and examination for pulse 
rate and blood pressure was carried out prior to 
receiving blood transfusion. Serum Ferritin analysis 
was performed by chemiluminanse  technique. 
 A standard 12 lead ECG was performed at a paper 
speed of 25 mm/sec, which was then studied for 
changes by a consultant cardiologist, who was blinded 
to the clinical status of the patient. Three successive 
ECG complexes were studied in each lead. 
Tachycardia was defined as a heart rate of more than 
100/minute.6 Long QT interval was defined as a 
corrected QT interval of more than 450 milli-seconds 
(ms) in males and more than 460 ms in females. 
Electrocardiographic criteria for left ventricular 
hypertrophy (LVH) was a sum of S V1 and RV5 
voltages of more than 35mm.6 Right ventricular 
hypertrophy (RVH) was diagnosed by R wave in the 
right precordial leads. 7  A patient was labelled as 
having pathological T wave inversion, if inversion was 
observed in at least two leads other than V1-3 which is 
considered to be normal juvenile pattern.8  
The patients were divided into 3 groups on the basis of 
their ferritin levels: Group I comprised of  33 patients 
with ferritin level  < 2500 ng/mL, Group II of  48 
patients with ferritin level between 2500- 5000ng/mL, 
and Group III of  54 patients with ferritin level > 
5000ng/mL . 
For quantitative variables, descriptive statistics was 
used to calculate mean and standard deviation. A Chi 
Square test was used for finding association between 
different ECG changes and serum ferritin levels.  P-
value of <0.05 was considered to be statistically 
significant. 
Results 
In this study group of 135 patients of BTM, there were 
51 % males. Patients’ ages ranged from 7-30 years, and 
a large proportion (50.4%) were in the 7-14 year age 
group.The mean serum ferritin level of patients was 
6062.61 + 3641.796 ng/ml.  There was no significant 
difference between the mean ferritin levels in males 
and females (6340.90 +3692.183ng/ml and 5771.67+ 
3593.22 ng/ml, respectively). (p =0.366).Interpretation 
of electrocardiographic recordings revealed that one or 
more abnormal findings were observed in 88.1% of 
patients. (Table 1). Majority ( 91.3%) of male and 84.3 
% of female patients showed ECG changes and the 
entire oldest  age group(23-30 years) was affected. 
(Table 2) The most commonly observed finding was 
flattening of the T wave, followed by arrthymias, 
tachycardia, pathological T wave inversions, long QT 
interval, LVH and RVH .(Table3; Figure 1). 
Table1:Beta Thalassaemia Major-Frequency of 
ECG changes 
ECG Change/s n= (135) Percentage 
Observed 119 88.1 
Not Observed 16 11.9 
 
Table 2: Beta Thalassaemia major-ECG changes 
according to gender and age 
Demographic variables No(%) 
Gender 
Male (n=69) 63(91.3%) 
Female (n=66) 56 (84.8%) 
Total (n=135) 119(88.1%) 
Age 
groups 
(years) 
7-14 (n=68) 58 (85.3%) 
15-22 (n=57) 51(89.5%) 
23-30 (n=10) 10 (100%) 
 
Table 3: Beta Thalassaemia major -  ECG 
changes observed * (n=119) 
ECG Change No Percentage 
T wave change-flattening 105 88.2 
Arrthymias 62 52.1 
Tachycardia 53 44.5 
Pathologic T wave inversion 46 38.7 
Long QT interval 34 28.6 
LVH 18 15.1 
RVH 4 3.4 
  *Patients often showed more than one type of ECG change 
 
Table 4: Frequency of different ECG changes 
observed in  three groups based on ferritin levels 
  
Group I 
Ferritin 
<2500ng/ml 
Group II 
Ferritin 
2500-
5000ng/ml 
Group 
III 
Ferritin
>5000 
ng/ml p-Value 
  n=33 n= 48 n= 54 
 Sinus 
Bradycardia 0 0 0 -- 
Sinus 
Tachycardia 15 19 24 0.84 
Sinus Arrthymia 17 28 28 0.76 
Long QT interval 3 6 25 0.001** 
T wave 
change(flattening) 28 37 40 0.497 
Pathologic T 
wave inversion 9 16 24 0.235 
Left Ventricular 
Hypertrophy 4 7 7 0.95 
Right Ventricular 
Hypertrophy 1 3 0 0.39 
**=highly significant 
 
Comparison of the ECG changes of patients in the 
three ferritin groups (Table4) showed that long QT 
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interval was significantly associated with high ferritin 
levels (p =0.001) whereas no association was observed 
for the other ECG changes and ferritin levels (Table 4).  
 
 
Figure 1: ECG of  a beta thalassaemia major Patient: T- 
wave inversion in Leads III, aVF and V1-5, along with 
prolongation of the QT interval.   
 
Discussion 
This study adds to the work done, with regard to the 
use of electrocardiography in TM patients for the 
detection of cardiomyopathy due to iron deposition. 
The changes that take place due to iron deposition in 
the cardiac tissues of these patients, are  degeneration, 
fibrosis, and dysfunction.5 Improved prospects for 
survival, without cardiac disease, are observed in 
thalassemia major patients, receiving regular blood 
transfusions, when their serum ferritin levels remain 
below 2,500 ng /ml.9  
 T-wave flattening and inversion observed in these 
patients is believed to be indicative of cardiac 
ischaemia, while tachycardia may be explained as a 
physiological compensation for anaemia which exists 
in these patients.4 The QT interval signifies ventricular 
depolarization and repolarization. 10  Increased levels 
of  intracellular iron disrupts the function of the 
sodium channels which cause depolarization in the 
cardiac action potential.  Repolarization abnormalities 
are also observed which are due to altered functioning 
of the delayed rectifier potassium and  calcium 
channels.1, 11 Prolongation of the QT interval predicts a 
higher risk of fatal arrthymias and sudden demise.10 
Hastened vascular aging and increased cardiac output, 
in thalassemia patients, have been suggested as 
reasons for left ventricular hypertrophy.4,11 The right 
ventricular hypertrophy, observed in these subjects 
may be attributed to a gradually increasing pulmonary 
vascular resistance leading to the development of 
pulmonary hypertension.11  Pulmonary arterial 
hypertension has been seen to have a prevalence of 6% 
in patients of thalassemia and sickle cell disease.12   
Inversion of T- wave, tachycardia, and broad QRS 
complexes are important ECG signs of impending 
heart failure in patients with Thalassemia major, and 
the presence of at least two of these three changes 
gives a sensitivity of 81% and a specificity of 91% in 
predicting the development of  heart failure.13  Serum 
ferritin rise of 1000 ng/ml, increases the possibility of 
developing these ECG changes by 27- 40%.13    
 
Conclusion 
1. Electrocardiography can be used for monitoring 
TM patients for the development of cardiac 
complications, as myocardial iron load cannot be 
predicted from serum ferritin levels alone. 
2. In the absence of T2*MRI , electrocardiography is 
an effective substitute to assess cardiac damage in 
beta thalassaemia major patients. 
3. T- wave changes and QT interval prolongation are 
considered the most sensitive measure of iron 
loading.  
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